Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
BMJ Open|June 2, 2026
Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocolKeisuke Koroki, Masaru Wakatsuki, Sadahisa Ogasawara, et al.
Investigational New Drugs|June 6, 2024
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)Kazufumi Kobayashi, Sadahisa Ogasawara, Ei Itobayashi, et al.
Biochemical and Biophysical Research Communications|December 31, 2022
Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cellsTerunao Iwanaga, Tetsuhiro Chiba, Masato Nakamura, et al.
Liver Cancer|February 28, 2022
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular CarcinomaKazufumi Kobayashi, Sadahisa Ogasawara, Aya Takahashi, et al.
BMC Gastroenterology|April 2, 2023
Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practiceSae Yumita, Sadahisa Ogasawara, Miyuki Nakagawa, et al.
Liver Cancer|November 1, 2021
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular CarcinomaKeisuke Koroki, Naoya Kanogawa, Susumu Maruta, et al.
Cancer|November 25, 2022
Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practiceMiyuki Nakagawa, Masanori Inoue, Sadahisa Ogasawara, et al.
Pageof 5